EPT - Condensed Consolidated Statements of Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Distributions in excess of accumulated earnings	Accumulated other comprehensive income, net	Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2023		64,203
Balance at period beginning at Dec. 31, 2023	$ 5,593,978	$ 6	$ 6,656,720	$ (1,267,536)	$ 33,556	$ 171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	509,613			484,069		25,544
Change in fair value of derivatives and amortization of swap settlements	(15,925)				(15,382)	(543)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		58
Stock option and restricted stock plans, net	12,313		12,313
Sale of common stock, net	(580)		(580)
Equity based compensation costs	5,734		5,539			195
Changes in the redemption value of redeemable noncontrolling interest	(2,293)		(2,436)			143
Changes in noncontrolling interest from acquisition	24,930					24,930
Distributions to noncontrolling interest	(26,193)					(26,193)
Redemptions of noncontrolling interest (in shares)		6
Redemptions of noncontrolling interest	(1,076)		(292)			(784)
Common stock dividends	(472,141)			(472,141)
Balance at period end (in shares) at Sep. 30, 2024		64,267
Balance at period end at Sep. 30, 2024	5,628,360	$ 6	6,671,264	(1,255,608)	18,174	194,524
Balance at period beginning (in shares) at Jun. 30, 2024		64,210
Balance at period beginning at Jun. 30, 2024	5,654,500	$ 6	6,659,313	(1,216,557)	38,877	172,861
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	125,487			118,424		7,063
Change in fair value of derivatives and amortization of swap settlements	(21,433)				(20,703)	(730)
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		51
Stock option and restricted stock plans, net	11,351		11,351
Sale of common stock, net	(467)		(467)
Equity based compensation costs	1,991		1,923			68
Changes in the redemption value of redeemable noncontrolling interest	(609)		(813)			204
Changes in noncontrolling interest from acquisition	24,930					24,930
Distributions to noncontrolling interest	(9,118)					(9,118)
Redemptions of noncontrolling interest (in shares)		6
Redemptions of noncontrolling interest	(797)		(43)			(754)
Common stock dividends	(157,475)			(157,475)
Balance at period end (in shares) at Sep. 30, 2024		64,267
Balance at period end at Sep. 30, 2024	5,628,360	$ 6	6,671,264	(1,255,608)	18,174	194,524
Balance at period beginning (in shares) at Dec. 31, 2024		64,280
Balance at period beginning at Dec. 31, 2024	5,720,390	$ 6	6,668,047	(1,155,662)	24,655	183,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	617,028			589,093		27,935
Reversal of unrealized gains upon the sale of marketable debt securities	(17)				(16)	(1)
Change in fair value of derivatives and amortization of swap settlements	(17,571)				(16,977)	(594)
Change in fair value of marketable debt securities, net	201				194	7
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		49
Stock option and restricted stock plans, net	8,370		8,370
Sale of common stock, net	(280)		(280)
Equity based compensation costs	7,021		6,783			238
Changes in the redemption value of redeemable noncontrolling interest	1,103		1,314			(211)
Distributions to noncontrolling interest	(24,677)					(24,677)
Redemptions of noncontrolling interest (in shares)		(75)
Redemptions of noncontrolling interest	(13,475)		2,355			(15,830)
Common stock dividends	(496,566)			(496,566)
Balance at period end (in shares) at Sep. 30, 2025		64,404
Balance at period end at Sep. 30, 2025	5,801,527	$ 6	6,686,589	(1,063,135)	7,856	170,211
Balance at period beginning (in shares) at Jun. 30, 2025		64,404
Balance at period beginning at Jun. 30, 2025	5,805,914	$ 6	6,685,714	(1,062,146)	11,675	170,665
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	172,724			164,621		8,103
Reversal of unrealized gains upon the sale of marketable debt securities	(17)				(16)	(1)
Change in fair value of derivatives and amortization of swap settlements	(4,050)				(3,913)	(137)
Change in fair value of marketable debt securities, net	114				110	4
Issuance of common stock under:
Stock option and restricted stock plans, net	(41)		(41)
Sale of common stock, net	(179)		(179)
Equity based compensation costs	2,607		2,519			88
Changes in the redemption value of redeemable noncontrolling interest	3,176		3,016			160
Distributions to noncontrolling interest	(8,192)					(8,192)
Redemptions of noncontrolling interest	(4,919)		(4,440)			(479)
Common stock dividends	(165,610)			(165,610)
Balance at period end (in shares) at Sep. 30, 2025		64,404
Balance at period end at Sep. 30, 2025	$ 5,801,527	$ 6	$ 6,686,589	$ (1,063,135)	$ 7,856	$ 170,211